Last edition
News about "Interchangeable Status Pharma"
FDA Grants Interchangeable Status to Celltrion's Denosumab Biosimilars Stoboclo and Osenvelt
The interchangeability (IC) designation allows Stoboclo and Osenvelt to be substituted at the pharmacy level for their reference biologics without requiring prescriber consultation, in accordance with state pharmacy laws.
Interchangeable Status Pharma | 31/10/2025 | By Darshana | 157
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy
pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members